We would love to hear your thoughts about our site and services, please take our survey here.
Agree Davand - we may not be getting figures from Lyn but we can extrapolate from the MHC revenue of £3m in just two months how many YGEN are on course to process over this summer. Answer - loads!!!! YGEN very undervalued at these levels imho.
Wonder if this very positive news will dry up the seller? I mean, that £250k buy at 12.25 a couple of days ago was quickly countered by chunky sells at 12.13 so interesting to see if the seller(s) now take stock because a Boots/EasyJet tie up is genuinely capable of adding significant volume when passengers get directed there when booking their flight - it's a different dynamic to simply hoping they go to Boots generally. Much more targeted chance of volume sales imo.
The 12.23p and 12.24p etc are all buys, presumably to offset the 300k sell at 12.12 just out of interest
Another good contract for BIRD. Also, great link there FBT - all shaping up nicely for a long term, solid investment but always with the possibility of riding the tech wave and being either taken over or getting solid Tech II's on board. Exciting times ahead!
A late reported buy imo as reflected by the continuing increase in sp today. GLA
Now that's the reassurance we've been looking for! Sales Order book currently 127% higher than 2020, excellent 75% retention of Murat customers and for AK to say "The Directors are encouraged by the recent performance and view the outlook with increasing confidence", all adds up to an excellent RNS Update. Now perhaps, we can be given an appropriate sp to reflect the value and excellent prospects of the company!
Chairman Andrew Bentley has bought a few more which is very encouraging. Not enough to be ‘the’ buyer as such but similarly, it also suggests that, if it’s an outside party, the BoD don’t know who otherwise AB’s purchase wouldn’t be allowable. Interesting times with BIRD recently and just getting better. GLA
In the end though, twix, you’re getting ar*sed off simply because BMD mentioned a USA contract was imminent and everyone has taken this as fact. It may be but equally it may not but it has become THE central point to everyone’s views at the moment. It’s not Lyn’s fault that a rumour is causing this grief it’s ours. I don’t think the last few RNS’s have been ‘inferior news’ - part of 4 huge govt contracts, largest Middle East and Africa distributor tie up - these are very ‘superior news’ - I say again, get rid of the seller and the sp will fly. We are a superb company imo and maybe a USA. Contract will come but that shouldn’t blank out the fundamentals which are very strong. I’m staying.
The problem to date has been a simple one - the MM’s Mark it up based on the latest RNS and run straight into some large sells and so Mark it back down again. There is a large seller out there and has been for some time. As and when they stop, the sp will bounce probably a long way very quickly as most shares are in the hands of LTH’s. We have no idea where the seller is in their cycle but that’s what has been happening following all the latest positive RNS’s so patience required - once they’ve gone, we’ll also go.....UP!!
There is one other slight possibility although unlikely. It may be that the BoD are selling to allow another identified party to buy at a pre-agreed level before the sp rises on other news or results. I know it sounds implausible but, the shares are tightly held and, assuming I wanted xyz to invest in my company for the longer term, if xyz went into the market they would create an sp surge. On the other hand, if the BoD are sellers, a) it reduces the sp, b) there are shares available to buy for xyz so that c) they get in and the sp brakes can come off as suggested to the ultimate larger benefit of all including the BoD who sold part of their holding. The old adage of its better to have 10% of a £100m company than 20% of a £20m company.
Again, as I said at the beginning, probably implausible, but it is a possibility and there is now buying after those sales. GLA
That order would have taken a bit of time to fill! Hopefully a buy!
Broker note out reconfirming target at 160p
http://www.allenbycapital.com/research_1213_1493680808.pdf
GLA
Bakky if we stay too low for too long, we’ll be a definite takeover target for a large Pharma surely. MM’s simply cannot keep the price up or down in the face of grown up selling or buying.
Twix, there is a crumb of comfort re your feelings on the BoD. In August and September last year, they bought over 1.4m shares (via a Placing at 17p a share and market buys of 17-18p) at an average of around 17.5p so they are about 4.5p per share (or c.25%) down at the moment as well. In August and September last year, we had no discernible or tangible Covid strategy and therefore they were surely basing their investment on our core fundamental products. Since then, they tendered for the Govt contracts in December and, as has been well documented, won all 4 which we know will produce a massive uplift in revenue and profit. The market has not catapulted them into the stratosphere as has been the case for other Covid stocks when news has been announced but in my opinion, the only reason for that must be a constant sizeable seller. Whoever they are and whatever their reasons, it simply cannot last and I think a huge number of shares remain in superglue hands like yours and mine. It is only a matter of when and not if this sp rerates on a massive scale and none of us should get shaken out by one persistent seller. Once he's gone, there will only be upward pressure again especially when we get news on revenue from the Govt contracts in 2 or 3 months time - we must give YGEN that time to gain traction and sell those tests. If we do, i believe it will be incredibly rewarding in a relatively short time. GLA
Morning all - the 50% was only my speculation and not fact just to be crystal clear. That said though, a dominant brand/chain like Boots wouldn’t stock any product for a normal agent commission as they don’t class themselves as an ‘agent’ Davand but as a retailer with a dominant High St and online position. Also MHC are relatively small fry who desperately needed Boots rather than the other way round at the time so Boots would have negotiated a very favourable buy price. That’s all I’m saying really and, in any event, twix put out interesting revenue figures based on only £8 a test profit a few threads back so I do strongly agree we are massively undervalued and have been adding more at these levels. I am as baffled as everyone else as to why we are languishing at 13.5p - it’s crazy!
Maybe Bakky but the buying power and margin expectations of the UK’s no 1 Chemist means that MHC/YGEN perhaps share up to half the RRP but definitely no more and quite possibly significantly less. Boots know full well who they are and any provider would fall over themselves to service their stores so the buy price may be very low. Hope not but...